Dual blockade of the renin-angiotensin-aldosterone system in renal disease: what is the future?

被引：1
作者：
Stompor, Tomasz [1 ]
Undas, Anetta [2 ]
机构：
[1] Univ Warmia & Mazury, Dept Nephrol Hypertens & Internal Med, Olsztyn, Poland
[2] Jagiellonian Univ, John Paul Hosp 2, Coll Med, Inst Cardiol, Krakow, Poland
来源：
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE | 2014年 / 124卷 / 1-2期
关键词：
INHIBITION; ALISKIREN;
D O I：
10.20452/pamw.2087
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 73
页数：2
相关论文
共 6 条
  • [1] Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials
    Agodoa, L.
    Anderson, C.
    Asselbergs, F. W.
    Baigent, C.
    Black, H.
    Brenner, B.
    Brown, M.
    Bulpitt, C.
    Byington, R.
    Chalmers, J.
    Collins, R.
    Cutler, J.
    Dahlof, B.
    Davis, B.
    de Zeeuw, D.
    Dens, J.
    Estacio, R.
    Fagard, R.
    Fox, K.
    Fukui, T.
    Hansson, L.
    Holman, R.
    Hunsicker, L.
    Imai, Y.
    Ishii, M.
    Kanno, Y.
    Kostis, J.
    Kuramoto, K.
    Lewis, E.
    Lievre, M.
    Lindholm, L. H.
    Liu, L.
    Lubsen, J.
    Lueders, S.
    MacMahon, S.
    Malacco, E.
    Mancia, G.
    Matsuzaki, M.
    Neal, B.
    Nissen, S.
    Ohkubo, T.
    Ogihara, T.
    Pepine, C.
    Pfeffer, M.
    Pitt, B.
    Poole-Wilson, P.
    Poulter, N.
    Rahman, M.
    Remme, W.
    Remuzzi, G.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [2] Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
    Fried, Linda F.
    Emanuele, Nicholas
    Zhang, Jane H.
    Brophy, Mary
    Conner, Todd A.
    Duckworth, William
    Leehey, David J.
    McCullough, Peter A.
    O'Connor, Theresa
    Palevsky, Paul M.
    Reilly, Robert F.
    Seliger, Stephen L.
    Warren, Stuart R.
    Watnick, Suzanne
    Peduzzi, Peter
    Guarino, Peter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (20) : 1892 - 1903
  • [3] Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease
    Lizakowski, Slawomir
    Tylicki, Leszek
    Rutkowski, Przemyslaw
    Renke, Marcin
    Sulikowska, Beata
    Heleniak, Zbigniew
    Donderski, Rafal
    Bednarski, Rafal
    Przybylska, Milena
    Manitius, Jacek
    Rutkowski, Boleslaw
    [J]. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2013, 123 (05): : 221 - 227
  • [4] Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis
    Lv, Jicheng
    Ehteshami, Parya
    Sarnak, Mark J.
    Tighiouart, Hocine
    Jun, Min
    Ninomiya, Toshiharu
    Foote, Celine
    Rodgers, Anthony
    Zhang, Hong
    Wang, Haiyan
    Strippoli, Giovanni F. M.
    Perkovic, Vlado
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (11) : 949 - 957
  • [5] Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
    Parving, Hans-Henrik
    Brenner, Barry M.
    McMurray, John J. V.
    de Zeeuw, Dick
    Haffner, Steven M.
    Solomon, Scott D.
    Chaturvedi, Nish
    Persson, Frederik
    Desai, Akshay S.
    Nicolaides, Maria
    Richard, Alexia
    Xiang, Zhihua
    Brunel, Patrick
    Pfeffer, Marc A.
    Juncos, Luis
    Orias, Marcelo
    Kuschnir, Emilio
    Rusculleda, Marcelo
    Garcia, Sergio
    Farias, Eduardo
    Lema, Luis
    Hominal, Miguel
    Montana, Oscar
    Sala, Jorgelina
    Diaz, Monica
    Piskorz, Daniel
    Vita, Nestor
    Litwak, Leon
    Sinay, Isaac
    Marin, Marcos
    Massari, Pablo
    Majul, Claudio
    Aizemberg, D.
    Azize, Guillermo Moises
    Bartolacci, Ines
    Reboredo, Ana
    Vico, Marisa
    Milesi, Ricardo
    Sessa, Horacio
    Wassermann, Alfredo
    Margulis, Fernando
    Zangroniz, Pedro
    Watschinger, B.
    Prager, R.
    Toplak, H.
    Paulweber, B.
    Drexel, H.
    Francesconi, C.
    Foeger, B.
    Mayer, G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (23) : 2204 - 2213
  • [6] Telmisartan, ramipril, or both in patients at high risk for vascular events
    Yusuf, Salim
    Teo, Koon K.
    Pogue, Janice
    Dyal, Leanne
    Copland, Ingrid
    Schumacher, Helmut
    Ingelheim, Boehringer
    Dagenais, Gilles
    Sleight, Peter
    Anderson, Craig
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (15) : 1547 - 1559
1